Craven P A, Neidig M, DeRubertis F R
Biochem Pharmacol. 1985 Sep 1;34(17):3101-6. doi: 10.1016/0006-2952(85)90154-6.
A fatty acid stimulated, NADPH-independent pathway for the N-demethylation of 1,1-dimethylhydrazine (1,1-DMH) with the generation of HCHO was demonstrated in 10,000 g soluble fractions of colonic mucosal homogenates. Tetramethylhydrazine and, to a lesser extent, aminopyrine, but not 1,2-DMH or methylhydrazine, were also substrates for this reaction. Isolated superficial colonic epithelial cells metabolized 1,1-DMH at a faster rate than proliferative epithelial cells. Indomethacin, an inhibitor of cyclooxygenase activity, and 5,8,11,14-eicosatetraynoic acid (ETYA), an inhibitor of both cyclooxygenase and lipoxygenase activities, suppressed HCHO production from 1,1-DMH by 50 and 80%. However, in the presence of indomethacin or ETYA, arachidonate hydroperoxide stimulated HCHO formation. This suggested a peroxidative mechanism for 1,1-DMH metabolism, related in part to prostaglandin synthesis. A possible role for lipoxygenase activity in mediating 1,1-DMH metabolism was suggested by the ability of linoleate, which did not increase prostaglandin synthesis, to stimulate 1,1-DMH metabolism and by the fact that ETYA was more effective than indomethacin as an inhibitor of 1,1-DMH metabolism. The fatty acid stimulated pathway for N-demethylation was clearly distinct from the mixed function oxidase activities. NADPH did not stimulate 1,1-DMH metabolism to HCHO. 7,8-Benzoflavone or SKF-525A, inhibitors of cytochrome P-450, and methimazole, an inhibitor of N-demethylation catalyzed by the hepatic microsomal FAD-containing monooxygenase, did not suppress HCHO formation. To the extent that 1,1-DMH and tetramethylhydrazine reach the colon unchanged, the results suggest that fatty acid stimulated cooxidation pathways in colonic mucosa may contribute to the metabolism of these agents. Metabolism by superficial cells which are destined to slough may be an important defense mechanism against the toxic and carcinogenic actions of these hydrazines in colon.
在结肠黏膜匀浆的10,000 g可溶性组分中,证实了一种脂肪酸刺激的、不依赖NADPH的1,1 - 二甲基肼(1,1 - DMH)N - 去甲基化途径,该途径会生成甲醛。四甲基肼以及程度稍低的氨基比林也是此反应的底物,但1,2 - DMH或甲基肼不是。分离出的结肠浅表上皮细胞代谢1,1 - DMH的速率比增殖性上皮细胞更快。环氧化酶活性抑制剂吲哚美辛以及环氧化酶和脂氧合酶活性抑制剂5,8,11,14 - 二十碳四烯酸(ETYA)可使1,1 - DMH产生的甲醛减少50%和80%。然而,在吲哚美辛或ETYA存在的情况下,花生四烯酸氢过氧化物会刺激甲醛生成。这表明1,1 - DMH代谢存在一种过氧化机制,部分与前列腺素合成有关。亚油酸虽不增加前列腺素合成,但能刺激1,1 - DMH代谢,且ETYA作为1,1 - DMH代谢抑制剂比吲哚美辛更有效,这提示脂氧合酶活性在介导1,1 - DMH代谢中可能发挥作用。脂肪酸刺激的N - 去甲基化途径明显不同于混合功能氧化酶活性。NADPH不会刺激1,1 - DMH代谢生成甲醛。细胞色素P - 450抑制剂7,8 - 苯并黄酮或SKF - 525A以及肝微粒体含FAD单加氧酶催化的N - 去甲基化抑制剂甲巯咪唑均不会抑制甲醛生成。就1,1 - DMH和四甲基肼未改变地到达结肠而言,结果表明结肠黏膜中脂肪酸刺激的共氧化途径可能有助于这些物质的代谢。注定会脱落的浅表细胞的代谢可能是结肠抵御这些肼类物质毒性和致癌作用的重要防御机制。